Flixotide Evohaler is a prescription inhaler containing 125 micrograms of fluticasone propionate per metered dose. Manufactured by GlaxoSmithKline (GSK), this CFC-free inhaler provides 120 metered actuations for the treatment of asthma and respiratory conditions. The inhaler delivers a precise 125 microgram dose of fluticasone propionate with each actuation. As a prescription medication, it should be used only as directed by a healthcare provider and kept out of reach of children. The orange-colored inhaler device is designed for ease of use and includes a dose counter to track remaining medication.